Clinical Trials

Showing trials with last updates posted in 2015.

NCT01318434 | COMPLETED | PHASE2/PHASE3
342 participants
NCT00827619 | COMPLETED | NA
110 participants

Zilver® Flex™ Vascular Stent Study

Study Type:
INTERVENTIONAL
Last Updated:
2015-12-04
Start Date:
2009-02-28
Completion:
2011-11-30
Conditions
  • Peripheral Arterial Disease (PAD)
Interventions
  • DEVICE
No Results Yet
NCT00538187 | TERMINATED | PHASE1
18 participants

Obatoclax and Bortezomib in Treating Patients With Aggressive Relapsed or Recurrent Non-Hodgkin Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2015-12-04
Start Date:
2007-12-31
Completion:
2011-04-30
Conditions
  • Adult Non-Hodgkin Lymphoma
  • Recurrent Adult Diffuse Large Cell Lymphoma
  • Recurrent Grade 1 Follicular Lymphoma
  • Recurrent Grade 2 Follicular Lymphoma
  • Recurrent Grade 3 Follicular Lymphoma
  • Recurrent Mantle Cell Lymphoma
  • Recurrent Marginal Zone Lymphoma
  • Recurrent Small Lymphocytic Lymphoma
Interventions
  • DRUG
  • OTHER
No Results Yet
NCT00459212 | COMPLETED | PHASE1
24 participants

GTI-2040 in Treating Patients With Relapsed, Refractory, or High-Risk Acute Leukemia, High-Grade Myelodysplastic Syndromes, or Refractory or Blastic Phase Chronic Myelogenous Leukemia

Study Type:
INTERVENTIONAL
Last Updated:
2015-12-04
Start Date:
2007-03-31
Completion:
2010-12-31
Conditions
  • Acute Undifferentiated Leukemia
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)
  • Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)
  • Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)
  • Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)
  • Blastic Phase Chronic Myelogenous Leukemia
  • de Novo Myelodysplastic Syndromes
  • Previously Treated Myelodysplastic Syndromes
  • Recurrent Adult Acute Lymphoblastic Leukemia
  • Recurrent Adult Acute Myeloid Leukemia
  • Relapsing Chronic Myelogenous Leukemia
  • Secondary Acute Myeloid Leukemia
  • Secondary Myelodysplastic Syndromes
  • Untreated Adult Acute Lymphoblastic Leukemia
  • Untreated Adult Acute Myeloid Leukemia
Interventions
  • DRUG
  • PROCEDURE
No Results Yet
NCT00062075 | COMPLETED | PHASE2
47 participants

Romidepsin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Study Type:
INTERVENTIONAL
Last Updated:
2015-12-04
Start Date:
2003-05-31
Completion:
2007-03-31
Conditions
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • Adult Acute Myeloid Leukemia With Del(5q)
  • Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)
  • Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)
  • Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)
  • Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)
  • Adult Acute Promyelocytic Leukemia (M3)
  • Recurrent Adult Acute Myeloid Leukemia
Interventions
  • DRUG
No Results Yet
NCT00039117 | COMPLETED | PHASE1
32 participants

Oblimersen, Cytarabine, and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia

Study Type:
INTERVENTIONAL
Last Updated:
2015-12-04
Start Date:
2002-04-30
Completion:
2003-09-30
Conditions
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)
  • Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)
  • Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)
  • Secondary Acute Myeloid Leukemia
  • Untreated Adult Acute Myeloid Leukemia
Interventions
  • BIOLOGICAL
  • DRUG
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page